Literature DB >> 7283050

Thyroid cancer: some basic considerations.

H J Wanebo, W Andrews, D L Kaiser.   

Abstract

From these data and data from the literature, our recommended treatment for well-differentiated cancer is as follows: For papillary cancer, resection should be adequate to encompass the entire tumor, which in most cases would be complete lobectomy and possibly isthmusectomy. Prophylactic neck dissection is of no value; therapeutic modified neck dissection should be done for stage II disease. Follicular cancer can be treated by lobectomy (for small lesions) or subtotal thyroidectomy. Although total or near-total thyroidectomy may be required in selected patients with large primary cancers or in those with extensive capsular invasion or extrathyroid extension, the number of cases indicating this is small. There were only a few such patients with large primaries requiring total thyroidectomy in this study. Total thyroidectomy is best avoided in most cases. considering the price of hypoparathyroidism and the lack of a significant improvement in survival compared with lesser ablative techniques. Postoperative ablation with iodine-131 did not improve survival in staged patients with papillary cancer (the number of patients with follicular cancer was too small for analysis). Postoperative thyroid suppression by exogenous thyroid hormone postoperatively appeared to improve survival. Although the data were not adequate for evaluation in follicular cancer, there seems to be no reason not to use this postoperatively in high risk patients with either papillary or follicular cancer.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283050     DOI: 10.1016/0002-9610(81)90378-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

Review 1.  Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

2.  A retrospective study on the efficacy of cervical lymph node dissection in well-differentiated carcinoma of the thyroid.

Authors:  M Noguchi; T Kumaki; T Taniya; T Nakano; M Segawa; N Ohta; K Iwasa; I Miyazaki; Y Mizukami; T Michigishi
Journal:  Jpn J Surg       Date:  1990-03

3.  Differentiated carcinoma of the thyroid gland.

Authors:  Z Steiner; J Abrahamson
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

4.  Induction of discriminant function concerning postoperative local recurrence or distant metastasis in 589 patients with differentiated thyroid cancer.

Authors:  Y Mori; K Takaya; Y Miyata; S Satomi; T Sasaki; Y Taguti; S Mori; Y Sekita; N Matoba; H Kurihara
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Differentiated carcinoma of the thyroid gland.

Authors:  O Ozaki; T Notsu; K Hirai; T Mori
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

6.  Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer.

Authors:  O H Clark
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

7.  Apoptosis and proliferative activity in thyroid tumors.

Authors:  A Yoshida; Y Nakamura; T Imada; T Asaga; A Shimizu; M Harada
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

8.  Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)

Authors:  M Coburn; D Teates; H J Wanebo
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

Review 9.  Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

10.  Classification of papillary cancer of the thyroid based on prognosis.

Authors:  S Noguchi; N Murakami; H Kawamoto
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.